Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean 9,10 801 0?
Displaying drugs 651 - 675 of 1455 in total

MRK-003

MRK-003 is a potent and selective γ-secretase inhibitor developed by Merck. It is the preclinical analog of MK-0752, a drug in clinical development.
Investigational

SYD-003

Investigational

MV-NB-02

Investigational

MRG-003

MRG-003 is a recombinant humanized anti-human epidermal growth factor receptor monoclonal antibody conjugated to monomethyl auristatin E.
Investigational

ACP-015

Investigational

SIG-001

SIG-001 is a cultured human retinal pigment epithelial cell line (ARPE-19) genetically modified with a non-viral vector to express B domain deleted human factor VIII protein, encapsulated within two-layer modified alginate spheres.
Investigational

RST-001

RST-001 is a non-replicating recombinant adeno-associated virus vector containing a fragment of the gene encoding channel rhodopsin-2 protein.
Investigational

NBL-015

Investigational

FCX-013

FCX-013 consists of human dermal fibroblasts genetically modified with a lentiviral vector expressing metalloproteinase-1 (MMP-1).
Investigational

BREN-02

BREN-02 is a recombinant human homeoprotein Engrailed 1 (rhEN1).
Investigational

AV-0113

AV-0113 consists of IL-12 secreting dendritic cells loaded with autologous tumor lysate.
Investigational

AVB-001

AVB-001 is an encapsulated, engineered human ARPE-19 cell line that constitutively expresses the native human IL-2 cytokine
Investigational

ISP-001

ISP-001 consists of sleeping beauty transposon-engineered autologous plasmablasts for expression and delivery of alpha-L-iduronidase.
Investigational

Mazorelvimab

Investigational

NB-001

NB-001 has been investigated for the treatment of Recurrent Herpes Labialis.
Investigational

BS-001

BS-001 is a recombinant oncolytic herpes simplex virus type II (OH2) therapeutic injection (Vero cell) for human use (rHSV2hGM-CSF).
Investigational

AL-034

AL-034 (TQ-A3334) is an oral toll-like receptor 7 agonist developed for the treatment of chronic hepatitis B (CHB) viral infection.
Investigational

EI-001

Investigational

PTR-01

Investigational

LM-030

Investigational

LTI-03

LTI-03 is a caveolin-1 Scaffolding Domain 7-Mer
Investigational

HH-009

HH-009 is a recombinant human IgG4 monoclonal antibody against FGF19 being studied for the treatment of hepatocellular carcinoma.
Investigational

Pegtibatinase

Investigational

PF-03758309

PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors.
Investigational

Zamerovimab

Investigational
Displaying drugs 651 - 675 of 1455 in total